Evidence map›Paper›PMID 42441018›Full record

ReviewFrontiers in nutrition2026

Beyond adherence: refractory dyslipidaemia, the mediterranean diet, and the case for personalized diet-drug complementarity.

Roko Skrabic, Marko Kumric, Roko Santic, Ivna Skrabic, Nikola Pavlovic, Doris Rusic, Josko Bozic

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Roko SkrabicDepartment of Internal Medicine, Division of Nephrology and Dialysis, University Hospital of Split, Split, Croatia.
Marko KumricDepartment of Pathophysiology, University of Split School of Medicine, Split, Croatia.
Roko SanticDepartment of Pathophysiology, University of Split School of Medicine, Split, Croatia.
Ivna SkrabicDepartment of Paediatrics, University Hospital of Split, Split, Croatia.
Nikola PavlovicDepartment of Pathophysiology, University of Split School of Medicine, Split, Croatia.
Doris RusicDepartment of Pharmacy, University of Split School of Medicine, Split, Croatia.
Josko BozicDepartment of Pathophysiology, University of Split School of Medicine, Split, Croatia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiovascular disease (CVD) remains the leading cause of death worldwide, and atherogenic dyslipidaemia is one of its most modifiable drivers. The Mediterranean diet (MedDiet) is among the most extensively studied and best-supported dietary patterns for cardiovascular protection, yet meta-analyses show only modest and heterogeneous effects on the conventional lipid panel: typically 5%-15% reductions in LDL cholesterol, 10%-20% reductions in triglycerides and 3%-6% increases in HDL cholesterol, with very high between-study heterogeneity (

Indexed as

dyslipidaemiagut microbiotaLDL cholesterollipoprotein(a)mediterranean dietnon-responderPCSK9 inhibitorsstatins

Identifiers

PMID42441018
PMCPMC13334983

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.